These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 21811785

  • 1. Immunization with N-propionyl polysialic acid-KLH conjugate in patients with small cell lung cancer is safe and induces IgM antibodies reactive with SCLC cells and bactericidal against group B meningococci.
    Krug LM, Ragupathi G, Hood C, George C, Hong F, Shen R, Abrey L, Jennings HJ, Kris MG, Livingston PO.
    Cancer Immunol Immunother; 2012 Jan; 61(1):9-18. PubMed ID: 21811785
    [Abstract] [Full Text] [Related]

  • 2. Vaccination of small cell lung cancer patients with polysialic acid or N-propionylated polysialic acid conjugated to keyhole limpet hemocyanin.
    Krug LM, Ragupathi G, Ng KK, Hood C, Jennings HJ, Guo Z, Kris MG, Miller V, Pizzo B, Tyson L, Baez V, Livingston PO.
    Clin Cancer Res; 2004 Feb 01; 10(3):916-23. PubMed ID: 14871967
    [Abstract] [Full Text] [Related]

  • 3. Synthesis of sialyl Lewis(a) (sLe (a), CA19-9) and construction of an immunogenic sLe(a) vaccine.
    Ragupathi G, Damani P, Srivastava G, Srivastava O, Sucheck SJ, Ichikawa Y, Livingston PO.
    Cancer Immunol Immunother; 2009 Sep 01; 58(9):1397-405. PubMed ID: 19190907
    [Abstract] [Full Text] [Related]

  • 4. Vaccination of patients with small-cell lung cancer with synthetic fucosyl GM-1 conjugated to keyhole limpet hemocyanin.
    Krug LM, Ragupathi G, Hood C, Kris MG, Miller VA, Allen JR, Keding SJ, Danishefsky SJ, Gomez J, Tyson L, Pizzo B, Baez V, Livingston PO.
    Clin Cancer Res; 2004 Sep 15; 10(18 Pt 1):6094-100. PubMed ID: 15447995
    [Abstract] [Full Text] [Related]

  • 5. Consistent antibody response against ganglioside GD2 induced in patients with melanoma by a GD2 lactone-keyhole limpet hemocyanin conjugate vaccine plus immunological adjuvant QS-21.
    Ragupathi G, Livingston PO, Hood C, Gathuru J, Krown SE, Chapman PB, Wolchok JD, Williams LJ, Oldfield RC, Hwu WJ.
    Clin Cancer Res; 2003 Nov 01; 9(14):5214-20. PubMed ID: 14614001
    [Abstract] [Full Text] [Related]

  • 6. Thomsen-Friedenreich (TF) antigen as a target for prostate cancer vaccine: clinical trial results with TF cluster (c)-KLH plus QS21 conjugate vaccine in patients with biochemically relapsed prostate cancer.
    Slovin SF, Ragupathi G, Musselli C, Fernandez C, Diani M, Verbel D, Danishefsky S, Livingston P, Scher HI.
    Cancer Immunol Immunother; 2005 Jul 01; 54(7):694-702. PubMed ID: 15726361
    [Abstract] [Full Text] [Related]

  • 7. A preclinical study comparing approaches for augmenting the immunogenicity of a heptavalent KLH-conjugate vaccine against epithelial cancers.
    Ragupathi G, Koide F, Sathyan N, Kagan E, Spassova M, Bornmann W, Gregor P, Reis CA, Clausen H, Danishefsky SJ, Livingston PO.
    Cancer Immunol Immunother; 2003 Oct 01; 52(10):608-16. PubMed ID: 12811527
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Selection of GM2, fucosyl GM1, globo H and polysialic acid as targets on small cell lung cancers for antibody mediated immunotherapy.
    Livingston PO, Hood C, Krug LM, Warren N, Kris MG, Brezicka T, Ragupathi G.
    Cancer Immunol Immunother; 2005 Oct 01; 54(10):1018-25. PubMed ID: 15926079
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Induction of antibodies against GD3 ganglioside in melanoma patients by vaccination with GD3-lactone-KLH conjugate plus immunological adjuvant QS-21.
    Ragupathi G, Meyers M, Adluri S, Howard L, Musselli C, Livingston PO.
    Int J Cancer; 2000 Mar 01; 85(5):659-66. PubMed ID: 10699946
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Induction of antibodies against GM2 ganglioside by immunizing melanoma patients using GM2-keyhole limpet hemocyanin + QS21 vaccine: a dose-response study.
    Chapman PB, Morrissey DM, Panageas KS, Hamilton WB, Zhan C, Destro AN, Williams L, Israel RJ, Livingston PO.
    Clin Cancer Res; 2000 Mar 01; 6(3):874-9. PubMed ID: 10741710
    [Abstract] [Full Text] [Related]

  • 17. Phase III multicenter clinical trial of the sialyl-TN (STn)-keyhole limpet hemocyanin (KLH) vaccine for metastatic breast cancer.
    Miles D, Roché H, Martin M, Perren TJ, Cameron DA, Glaspy J, Dodwell D, Parker J, Mayordomo J, Tres A, Murray JL, Ibrahim NK, Theratope® Study Group.
    Oncologist; 2011 Mar 01; 16(8):1092-100. PubMed ID: 21572124
    [Abstract] [Full Text] [Related]

  • 18. Vaccine therapy for small cell lung cancer.
    Krug LM.
    Semin Oncol; 2004 Feb 01; 31(1 Suppl 1):112-6. PubMed ID: 14981589
    [Abstract] [Full Text] [Related]

  • 19. Vaccination of high-risk breast cancer patients with mucin-1 (MUC1) keyhole limpet hemocyanin conjugate plus QS-21.
    Gilewski T, Adluri S, Ragupathi G, Zhang S, Yao TJ, Panageas K, Moynahan M, Houghton A, Norton L, Livingston PO.
    Clin Cancer Res; 2000 May 01; 6(5):1693-701. PubMed ID: 10815887
    [Abstract] [Full Text] [Related]

  • 20. Pilot study of a heptavalent vaccine-keyhole limpet hemocyanin conjugate plus QS21 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer.
    Sabbatini PJ, Ragupathi G, Hood C, Aghajanian CA, Juretzka M, Iasonos A, Hensley ML, Spassova MK, Ouerfelli O, Spriggs DR, Tew WP, Konner J, Clausen H, Abu Rustum N, Dansihefsky SJ, Livingston PO.
    Clin Cancer Res; 2007 Jul 15; 13(14):4170-7. PubMed ID: 17634545
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.